Association of MAOA, 5-HTT, and NET promoter polymorphisms with gene expression and protein activity in human placentas

Physiological Genomics

Volumn 42, Issue 1, 2010, Pages 85-92

  Zhang, Huiping ^a,b   Smith, Graeme N ^a   Liu, Xudong ^a,b   Holden, Jeanette J A ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b Ongwanada Resource Centre   (Canada)

Author keywords

Fetal neuro development; Monoamine oxidase A; mRNA levels; Neurotransmitters; Norepinephrine transporter; Serotonin transporter; Transporter activity

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; MESSENGER RNA; NORADRENALIN TRANSPORTER; SEROTONIN TRANSPORTER;

AMINE TRANSPORT; ARTICLE; BRAIN DEVELOPMENT; CONTROLLED STUDY; DNA POLYMORPHISM; DOPAMINE UPTAKE; ENZYME ACTIVITY; FEMALE; FETUS; FETUS DEVELOPMENT; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MALE; NORADRENALIN UPTAKE; PLACENTA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; SEROTONIN UPTAKE; VARIABLE NUMBER OF TANDEM REPEAT;

DOPAMINE; FEMALE; FETUS; GENE EXPRESSION; GENOTYPE; HUMANS; MALE; MONOAMINE OXIDASE; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PLACENTA; POLYMORPHISM, GENETIC; PREGNANCY; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 77953184026     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00220.2009     Document Type: Article

References (55)

1. Aklillu E, Karlsson S, Zachrisson OO, Ozdemir V, Agren H. Association of MAOA gene functional promoter polymorphism with CSF dopamine turnover and atypical depression. Pharmacogenet Genomics 19: 267-275, 2009.
2. Anderson GM, Gutknecht L, Cohen DJ, Brailly-Tabard S, Cohen JH, Ferrari P, Roubertoux PL, Tordjman S. Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia. Mol Psychiatry 7: 831-836, 2002.
3. Balciuniene J, Emilsson L, Oreland L, Pettersson U, Jazin E. Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. Hum Genet 110: 1-7, 2002.
4. Balkovetz DF, Tiruppathi C, Leibach FH, Mahesh VB, Ganapathy V. Evidence for an imipramine-sensitive serotonin transporter in human placental brush-border membranes. J Biol Chem 264: 2195-2198, 1989. (Pubitemid 19057692)
5. Brune CW, Kim SJ, Salt J, Leventhal BL, Lord C, Cook EH Jr. 5-HTTLPR genotype-specific phenotype in children and adolescents with autism. Am J Psychiatry 163: 2148-2156, 2006.
6. Bzoskie L, Blount L, Kashiwai K, Humme J, Padbury JF. The contribution of transporter-dependent uptake to fetal catecholamine clearance. Biol Neonate 71: 102-110, 1997. (Pubitemid 27086940)
7. Carrasco G, Cruz MA, Dominguez A, Gallardo V, Miguel P, Gonzalez C. The expression and activity of monoamine oxidase A, but not of the serotonin transporter, is decreased in human placenta from pre-eclamptic pregnancies. Life Sci 67: 2961-2969, 2000.
8. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, Taylor A, Poulton R. Role of genotype in the cycle of violence in maltreated children. Science 297: 851-854, 2002.
9. Cohen IL, Liu X, Schutz C, White BN, Jenkins EC, Brown WT, Holden JJ. Association of autism severity with a monoamine oxidase A functional polymorphism. Clin Genet 64: 190-197, 2003.
10. Collier DA, Stober G, Li T, Heils A, Catalano M, Di BD, Arranz MJ, Murray RM, Vallada HP, Bengel D, Muller CR, Roberts GW, Smeraldi E, Kirov G, Sham P, Lesch KP. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1: 453-460, 1996.
11. Conroy J, Meally E, Kearney G, Fitzgerald M, Gill M, Gallagher L. Serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population. Mol Psychiatry 9: 587-593, 2004.
12. Contini V, Marques FZ, Garcia CE, Hutz MH, Bau CH. MAOA-uVNTR polymorphism in a Brazilian sample: further support for the association with impulsive behaviors and alcohol dependence. Am J Med Genet B Neuropsychiatr Genet 141B: 305-308, 2006.
13. Cook EH Jr, Courchesne R, Lord C, Cox NJ, Yan S, Lincoln A, Haas R, Courchesne E, Leventhal BL. Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 2: 247-250, 1997. (Pubitemid 27217689)
14. Denney RM, Koch H, Craig IW. Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAOA promoter-associated variable number tandem repeat. Hum Genet 105: 542-551, 1999.
15. Feinn R, Nellissery M, Kranzler HR. Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence. Am J Med Genet B Neuropsychiatr Genet 133B: 79-84, 2005.
16. Ganapathy V, Leibach FH. Human placenta: a direct target for cocaine action. Placenta 15: 785-795, 1994.
17. Gelernter J, Kruger S, Pakstis AJ, Pacholczyk T, Sparkes RS, Kidd KK, Amara S. Assignment of the norepinephrine transporter protein (NET1) locus to chromosome 16. Genomics 18: 690-692, 1993.
18. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 88: 83-87, 1999.
19. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP. Allelic variation of human serotonin transporter gene expression. J Neurochem 66: 2621-2624, 1996. (Pubitemid 26159101)
20. Hoefgen B, Schulze TG, Ohlraun S, von Widdern O, Höfels S, Gross M, Heidmann V, Kovalenko S, Eckermann A, Kölsch H, Metten M, Zobel A, Becker T, Nöthen MM, Propping P, Heun R, Maier W, Rietschel M. The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder. Biol Psychiatry 57: 247-251, 2005.
21. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, Murphy DL, Goldman D. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78: 815-826, 2006.
22. Iordanidou M, Tavridou A, Petridis I, Arvanitidis KI, Christakidis D, Vargemezis V, Manolopoulos VG. The serotonin transporter promoter polymorphism (5-HTTLPR) is associated with type 2 diabetes. Clin Chim Acta 411: 167-171, 2010.
23. Jonsson EG, Norton N, Gustavsson JP, Oreland L, Owen MJ, Sedvall GC. A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. J Psychiatr Res 34: 239-244, 2000.
24. Kim SJ, Cox N, Courchesne R, Lord C, Corsello C, Akshoomoff N, Guter S, Leventhal BL, Courchesne E, Cook EH Jr. Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder. Mol Psychiatry 7: 278-288, 2002.
25. Lasky-Su JA, Faraone SV, Glatt SJ, Tsuang MT. Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. Am J Med Genet B Neuropsychiatr Genet 133B: 110-115, 2005.
26. Lau YF, Chan KM. The putative testis-determining factor and related genes are expressed as discrete-sized transcripts in adult gonadal and somatic tissues. Am J Hum Genet 45: 942-952, 1989.
27. Lesch KP, Balling U, Gross J, Strauss K, Wolozin BL, Murphy DL, Riederer P. Organization of the human serotonin transporter gene. J Neural Transm Gen Sect 95: 157-162, 1994. (Pubitemid 2051960)
28. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274: 1527-1531, 1996.
29. Levy ER, Powell JF, Buckle VJ, Hsu YP, Breakefield XO, Craig IW. Localization of human monoamine oxidase-A gene to Xp11.23-114 by in situ hybridization: implications for Norrie disease. Genomics 5: 368-370, 1989.
30. Meyer-Lindenberg A, Buckholtz JW, Kolachana B, Hariri R, Pezawas L, Blasi G, Wabnitz A, Honea R, Verchinski B, Callicott JH, Egan M, Mattay V, Weinberger DR. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci USA 103: 6269-6274, 2006.
31. Pinto E, Reggers J, Gorwood P, Boni C, Scantamburlo G, Pitchot W, Ansseau M. The short allele of the serotonin transporter promoter polymorphism influences relapse in alcohol dependence. Alcohol Alcohol 43: 398-400, 2008.
32. Prasad PD, Hoffmans BJ, Moe AJ, Smith CH, Leibach FH, Ganapathy V. Functional expression of the plasma membrane serotonin transporter but not the vesicular monoamine transporter in human placental trophoblasts and choriocarcinoma cells. Placenta 17: 201-207, 1996.
33. Quandt K, Frech K, Karas H, Wingender E, Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23: 4878-4884, 1995. (Pubitemid 3008389)
34. Quaranta D, Bizzarro A, Marra C, Vita MG, Seripa D, Pilotto A, Sebastiani V, Mecocci P, Masullo C. Psychotic symptoms in Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: evidence for an association. J Alzheimers Dis 16: 173-180, 2009.
35. Ramamoorthy S, Leibach FH, Mahesh VB, Ganapathy V. Active transport of dopamine in human placental brush-border membrane vesicles. Am J Physiol Cell Physiol 262: C1189-C1196, 1992.
36. Retz W, Freitag CM, Retz-Junginger P, Wenzler D, Schneider M, Kissling C, Thome J, Rosler M. A functional serotonin transporter promoter gene polymorphism increases ADHD symptoms in delinquents: interaction with adverse childhood environment. Psychiatry Res 158: 123-131, 2008.
37. Rothenburg S, Koch-Nolte F, Thiele HG, Haag F. DNA methylation contributes to tissue- and allele-specific expression of the T-cell differentiation marker RT6. Immunogenetics 52: 231-241, 2001.
38. Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103: 273-279, 1998.
39. Sen S, Burmeister M, Ghosh D. Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet 127B: 85-89, 2004.
40. Sivasubramaniam SD, Finch CC, Billett MA, Baker PN, Billett EE. Monoamine oxidase expression and activity in human placentae from pre-eclamptic and normotensive pregnancies. Placenta 23: 163-171, 2002.
41. Stober G, Nothen MM, Porzgen P, Bruss M, Bonisch H, Knapp M, Beckmann H, Propping P. Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am J Med Genet 67: 523-532, 1996. (Pubitemid 126456809)
42. Sukonick DL, Pollock BG, Sweet RA, Mulsant BH, Rosen J, Klunk WE, Kastango KB, DeKosky ST, Ferrell RE. The 5-HTTPR*S/*L polymorphism and aggressive behavior in Alzheimer disease. Arch Neurol 58: 1425-1428, 2001. (Pubitemid 32845994)
43. Urwin RE, Bennetts B, Wilcken B, Lampropoulos B, Beumont P, Clarke S, Russell J, Tanner S, Nunn KP. Anorexia nervosa (restrictive subtype) is associated with a polymorphism in the novel norepinephrine transporter gene promoter polymorphic region. Mol Psychiatry 7: 652-657, 2002.
44. Urwin RE, Bennetts BH, Wilcken B, Lampropoulos B, Beumont PJ, Russell JD, Tanner SL, Nunn KP. Gene-gene interaction between the monoamine oxidase A gene and solute carrier family 6 (neurotransmitter transporter, noradrenalin) member 2 gene in anorexia nervosa (restrictive subtype). Eur J Hum Genet 11: 945-950, 2003.
45. Verhagen M, van der Meij A, Janzing JG, Arias-Vasquez A, Buitelaar JK, Franke B. Effect of the 5-HTTLPR polymorphism in the serotonin transporter gene on major depressive disorder and related comorbid disorders. Psychiatr Genet 19: 39-44, 2009.
46. Vitalis T, Fouquet C, Alvarez C, Seif I, Price D, Gaspar P, Cases O. Developmental expression of monoamine oxidases A and B in the central and peripheral nervous systems of the mouse. J Comp Neurol 442: 331-347, 2002.
47. Wang Y, Berndt TJ, Gross JM, Peterson MA, So MJ, Knox FG. Effect of inhibition of MAO and COMT on intrarenal dopamine and serotonin and on renal function. Am J Physiol Regul Integr Comp Physiol 280: R248-R254, 2001.
48. Weese-Mayer DE, Berry-Kravis EM, Maher BS, Silvestri JM, Curran ME, Marazita ML. Sudden infant death syndrome: association with a promoter polymorphism of the serotonin transporter gene. Am J Med Genet A 117A: 268-274, 2003. (Pubitemid 37063992)
49. Weyler W, Hsu YP, Breakefield XO. Biochemistry and genetics of monoamine oxidase. Pharmacol Ther 47: 391-417, 1990.
50. Weyler W, Salach JI. Purification and properties of mitochondrial monoamine oxidase type A from human placenta. J Biol Chem 260: 13199-13207, 1985. (Pubitemid 16209794)
51. Williams LM, Gatt JM, Kuan SA, Dobson-Stone C, Palmer DM, Paul RH, Song L, Costa PT, Schofield PR, Gordon E. A polymorphism of the MAOA gene is associated with emotional brain markers and personality traits on an antisocial index. Neuropsychopharmacology 34: 1797 - 1809, 2009.
52. Xie P, Kranzler HR, Poling J, Stein MB, Anton RF, Brady K, Weiss RD, Farrer L, Gelernter J. Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. Arch Gen Psychiatry 66: 1201-1209, 2009.
53. Yavarone MS, Shuey DL, Sadler TW, Lauder JM. Serotonin uptake in the ectoplacental cone and placenta of the mouse. Placenta 14: 149-161, 1993.
54. Yoo HJ, Lee SK, Park M, Cho IH, Hyun SH, Lee JC, Yang SY, Kim SA. Family- and population-based association studies of monoamine oxidase A and autism spectrum disorders in Korean. Neurosci Res 63: 172-176, 2009.
55. Yu YW, Tsai SJ, Hong CJ, Chen TJ, Chen MC, Yang CW. Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response. Neuropsychopharmacology 30: 1719-1723, 2005.